|02/22/17||ViewRay® to Participate in Upcoming Conferences|
|CLEVELAND, Feb. 22, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences.
The first conference is the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. This conference will allow institutional investors to meet with the Company but does not i... |
|01/24/17||Private Japanese Hospital Purchases ViewRay MRIdian System|
|CLEVELAND, Jan. 24, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Edogawa Hospital in Tokyo Japan has purchased a MRIdian system, the world's first and only clinical MRI-guided radiation therapy system, as part of an expansion of the hospital's cancer center.
The MRIdian system is a unique medical instrument that integrates an MRI with cobalt radiation delivery to treat cancer. Using the MRIdian system, clinicians can see soft tissue, and visualize and adjust the dose... |
|01/19/17||German Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg|
|Marks First Purchase of MRIdian Linac in Europe following CE Mark Approval
CLEVELAND, Jan. 19, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the German Research Foundation (DFG), a federal institution supporting research in Germany, has purchased a MRIdian Linac for installation and patient treatments at the University Clinic Heidelberg as part of its initiative for MRI-based radiation therapy.
The MRIdian Linac program will be headed by Medical Director and Profes... |
|01/18/17||ViewRay Raises $26.1 Million in Private Placement|
|Financing to Support Commercialization of MRIdian Linear Accelerator Technology
CLEVELAND, Jan. 18, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has raised aggregate gross proceeds of approximately $26.1 million through a private placement of its common stock and warrants. Puissance Capital Management led the financing and was joined by certain of ViewRay's existing investors, incl... |